nobiletin has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaleli, S; Ozkan, AD; Sarihan, M | 1 |
| Chen, AY; Chen, J; Chen, YC; Creed, A; Huang, H; Li, Z; Rankin, GO; Xu, G; Ye, X | 1 |
| Asamoto, M; Chewonarin, T; Ogawa, K; Shirai, T; Suzuki, S; Tanaka, T; Tang, MX | 1 |
| Asamoto, M; Hokaiwado, N; Ichikawa, K; Ogawa, K; Seeni, A; Shirai, T; Suzuki, S; Takahashi, S; Tanaka, T; Tang, M | 1 |
4 other study(ies) available for nobiletin and Cancer of Prostate
| Article | Year |
|---|---|
Evaluation of the Effects of Nobiletin on Toll-Like Receptor 3 Signaling Pathways in Prostate Cancer
Topics: Flavones; Humans; Male; Prostatic Neoplasms; Signal Transduction; Toll-Like Receptor 3 | 2021 |
Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells.
Topics: Blotting, Western; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Flavones; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Vascular Endothelial Growth Factor A | 2014 |
Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats.
Topics: Aberrant Crypt Foci; Adenocarcinoma; Animals; Carcinogens; Chemoprevention; Colonic Neoplasms; Flavones; Imidazoles; Male; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testis | 2011 |
Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells.
Topics: Adenocarcinoma; Animals; Animals, Genetically Modified; Antioxidants; Coumarins; Diet; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavones; Humans; Male; Plant Proteins, Dietary; Precancerous Conditions; Prostatic Neoplasms; Protective Agents; Rats; Tumor Cells, Cultured | 2007 |